TipRanks
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
US Market
MNPR
Monopar Therapeutics Inc
RESEARCH TOOLSreports
Want to see MNPR full AI Analyst Report?

Monopar Therapeutics Inc (MNPR) Stock News & Sentiment

581 Followers
Buy Rating Reiterated on Monopar as ALXN-1840 Advances in Wilson Disease; $125 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on Monopar as ALXN-1840 Advances in Wilson Disease; $125 Price Target Maintained
2M ago
MNPR
Boris Peaker Maintains Buy Rating on Monopar, Reaffirming Unchanged $130 Price Target on ALXN1840’s Strong Clinical and Regulatory Profile
Premium
Ratings
Boris Peaker Maintains Buy Rating on Monopar, Reaffirming Unchanged $130 Price Target on ALXN1840’s Strong Clinical and Regulatory Profile
2M ago
MNPR
BTIG’s Mukherjee Initiates Buy on Monopar Therapeutics, Citing Emerging Head & Neck Cancer Data and Favorable Risk‑Reward Setup
Premium
Ratings
BTIG’s Mukherjee Initiates Buy on Monopar Therapeutics, Citing Emerging Head & Neck Cancer Data and Favorable Risk‑Reward Setup
3M ago
MNPR
Maldonado Reiterates Buy on Monopar as ALXN1840 NDA Progress and Robust Clinical Data Drive Price Target Increase from $105 to $125
Premium
Ratings
Maldonado Reiterates Buy on Monopar as ALXN1840 NDA Progress and Robust Clinical Data Drive Price Target Increase from $105 to $125
3M ago
MNPR
Monopar Begins Rolling FDA NDA Submission for ALXN1840
Premium
Company Announcements
Monopar Begins Rolling FDA NDA Submission for ALXN1840
3M ago
8K
MNPR
Monopar Wins FDA Rare Pediatric Disease Designation
Premium
Company Announcements
Monopar Wins FDA Rare Pediatric Disease Designation
3M ago
8K
MNPR
Monopar Highlights Positive Phase 3 Wilson Disease Data
Premium
Company Announcements
Monopar Highlights Positive Phase 3 Wilson Disease Data
3M ago
8K
MNPR
More MNPR News >

MNPR News on the Web

Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (MNPR), Achieve Life Sciences (ACHV) and OptimizeRx (OPRX)
TipRanks News
Bullish
Monopar's ALXN1840 Gets FDA's Rare Pediatric Disease Designation For Wilson Disease
rttnews
Bullish
Monopar Therapeutics price target raised to $117 from $104 at BTIG
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Monopar Therapeutics Inc (MNPR) and Bio-Techne (TECH)
TipRanks News
Bullish
Monopar Therapeutics announces new FoCus trial analyses
TipRanks News
Bullish
Monopar Highlights Positive Phase 3 Wilson Disease Data
TipRanks News
Neutral
Top Biotech Gainers: BOLD Begins Anew, MNPR NDA Filing On Track, GALT Soars On FDA Alignment
rttnews
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is MNPR’s Media Buzz Sentiment?
Currently, no data Available
What is MNPR’s weekly average amount of articles?
In an average week, 1 articles about MNPR are published.
    What is MNPR’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    AMGNAmgen
    MCKMcKesson
    ONCBeOne Medicines
    NVSNovartis
    NTRANatera
    Showing the stocks with the most bullish news sentiment over the past week